Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG
- PMID: 24709209
- DOI: 10.1016/j.ijpharm.2014.04.008
Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG
Abstract
Though PEGylation has been widely used to enhance the accumulation of liposomes in tumor tissues through enhanced permeability and retention (EPR) effects, it still inhibits cellular uptake and affects intracellular trafficking of carriers. Active targeting molecules displayed better cell selectivity but were shadowed by the poor tumor penetration effect. Cell penetrating peptides could increase the uptake of the carriers but were limited by their non-specificity. Dual-ligand system may possess a synergistic effect and create a more ideal drug delivery effect. Based on the above factors, we designed a multistage liposome system co-modified with RGD, TAT and cleavable PEG, which combined the advantages of PEG, specific ligand and penetrating peptide. The cleavable PEG could increase the stability and circulation time of liposomes during circulation. After the passive extravasation to tumor tissues, the previously hidden dual ligands on the liposomes were exposed in a controlled manner at the tumor site through exogenous administration of a safe reducing agent L-cysteine. The RGD specifically recognized the integrins overexpressed on various malignant tumors and mediated efficient internalization in the synergistic effect of the RGD and TAT. Invitro cellular uptake and 3D tumor spheroids penetration studies demonstrated that the system could not only be selectively and efficiently taken up by cells overexpress ingintegrins but also penetrate the tumor cells to reach the depths of the avascular tumor spheroids. In vivo imaging and fluorescent images of tumor section further demonstrated that this system achieved profoundly improved distribution within tumor tissues, and the RGD and TAT ligands on C-R/T liposomes produced a strong synergistic effect that promoted the uptake of liposomes into cells after the systemic administration of L-cysteine. The results of this study demonstrated a tremendous potential of this multistage liposomes for efficient delivery to tumor tissue and selective internalization into tumor cells.
Keywords: Cleavable PEG; Multistage liposome; Synergistic effect; Tumor targeting.
Copyright © 2014 Elsevier B.V. All rights reserved.
Similar articles
-
Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.Mol Pharm. 2010 Oct 4;7(5):1816-26. doi: 10.1021/mp100171c. Epub 2010 Aug 11. Mol Pharm. 2010. PMID: 20701288
-
Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.Int J Pharm. 2013 Sep 15;454(1):31-40. doi: 10.1016/j.ijpharm.2013.06.048. Epub 2013 Jul 10. Int J Pharm. 2013. PMID: 23850793
-
Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol).J Pharm Sci. 2015 Mar;104(3):1160-73. doi: 10.1002/jps.24291. Epub 2014 Dec 1. J Pharm Sci. 2015. PMID: 25449709
-
15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting.J Control Release. 2015 May 10;205:58-69. doi: 10.1016/j.jconrel.2014.12.002. Epub 2014 Dec 4. J Control Release. 2015. PMID: 25483423 Review.
-
The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors.Biol Pharm Bull. 2013;36(6):892-9. doi: 10.1248/bpb.b13-00059. Biol Pharm Bull. 2013. PMID: 23727912 Review.
Cited by
-
pH-sensitive PEGylation of RIPL peptide-conjugated nanostructured lipid carriers: design and in vitro evaluation.Int J Nanomedicine. 2018 Oct 23;13:6661-6675. doi: 10.2147/IJN.S184355. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30425481 Free PMC article.
-
Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.Drug Des Devel Ther. 2019 Sep 17;13:3281-3290. doi: 10.2147/DDDT.S211168. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31571830 Free PMC article.
-
Diversity of PEGylation methods of liposomes and their influence on RNA delivery.Medchemcomm. 2019 Feb 12;10(3):369-377. doi: 10.1039/c8md00515j. eCollection 2019 Mar 1. Medchemcomm. 2019. PMID: 31015904 Free PMC article. Review.
-
Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer.Adv Drug Deliv Rev. 2018 May;130:50-57. doi: 10.1016/j.addr.2018.06.014. Epub 2018 Jun 26. Adv Drug Deliv Rev. 2018. PMID: 29958925 Free PMC article. Review.
-
Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides.Int J Nanomedicine. 2017 Feb 27;12:1517-1537. doi: 10.2147/IJN.S122859. eCollection 2017. Int J Nanomedicine. 2017. PMID: 28280323 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials